Journals / Cukurova Medical Journal / 2022 / Cilt: 47 - Sayı: 1

Effect of thymoquinone on ameliorating valproic acid-induced damage in pancreatic tissue of rats

Timokinon’un sıçanların pankreas dokusunda valproik asidin neden olduğu hasarı iyileştirmeye etkisi

Pages
350–359
Publication Date
2022-03-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: TQ may be useful for reducing the severity of VPA-induced pancreatic damage.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study was to evaluate the potential effect of thymoquinone (TQ) in preventing or treating valproic acid (VPA)-induced pancreatic injury, gene expressions and histopathological changes in pancreatic tissue of rats..
📊
Key Findings & Data:Materials and Methods: 21 male Spraque-Dawley rats were divided into 3 groups (n = 7): Control, VPA, VPA + TQ.
💡
Conclusion & Impact:Conclusion: TQ may be useful for reducing the severity of VPA-induced pancreatic damage.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:timokinon · valproik asit · apoptoz

Abstract

Purpose: The aim of this study was to evaluate the potential effect of thymoquinone (TQ) in preventing or treating valproic acid (VPA)-induced pancreatic injury, gene expressions and histopathological changes in pancreatic tissue of rats.. Materials and Methods: 21 male Spraque-Dawley rats were divided into 3 groups (n = 7): Control, VPA, VPA + TQ. Rats were treated orally with VPA (500 mg/kg/day) and TQ (50 mg/kg/day) for 14 days. On the 15th day of treatment, pancreatic tissue was resected for the analysis of the expression levels of histone deacetylase (HDAC1 and HDAC2) genes. Structural changes in pancreatic tissues were examined. Results: It was observed that VPA + TQ group had significantly higher HDAC1 and HDAC2 genes expression compared to the VPA group. Furthermore, the findings show that TQ therapy can protect pancreatic tissue against the negative effects of VPA on HDAC1 and HDAC2 gene expression. It also decreased the levels of NADPH oxidase-4 (NOX-4) and caspase-3 (CAS-3). Oxidative stress decreased, antioxidant activity increased and histopathological changes decreased in the VPA + TQ group compared to the VPA group. Pancreatic damage caused by VPA was attenuated due to TQ's antioxidative and antiapoptotic effects. Conclusion: TQ may be useful for reducing the severity of VPA-induced pancreatic damage.

Özet

Amaç: Bu çalışmanın amacı timokinonun (TQ) valproik asit (VPA) kaynaklı pankreas hasarını önleme veya tedavi etmedeki potansiyel etkisinin, sıçanların pankreas dokusundaki gen ekspresyonlarının ve histopatolojik değişikliklerin değerlendirilmesidir. Gereç ve Yöntem: 21 erkek Spraque-Dawley sıçanı 3 gruba ayrıldı (n = 7): Kontrol, VPA, VPA + TQ. Sıçanlar, 14 gün boyunca oral yoldan VPA (500 mg/kg/gün) ve TQ (50 mg/kg/gün) ile muamele edildi. Muamelenin 15. gününde, histon deasetilaz (HDAC1 ve HDAC2) genlerinin ekspresyon seviyelerinin analizi için pankreas dokusu çıkarıldı. Pankreas dokularındaki yapısal değişiklikler incelendi. Bulgular: VPA + TQ grubunun, VPA grubuna göre anlamlı derecede daha yüksek HDAC1 ve HDAC2 gen ekspresyonuna sahip olduğu görüldü. Ayrıca bulgularımız, TQ tedavisinin pankreas dokusunu VPA'nın HDAC1 ve HDAC2 gen ekspresyonu üzerindeki olumsuz etkilerine karşı koruyabildiğini göstermektedir. Ayrıca TQ NADPH oksidaz-4 (NOX-4) ve kaspaz-3 (CAS-3) düzeylerini de düşürdü. VPA+TQ grubunda VPA grubuna göre oksidatif stres azaldı, antioksidan aktivite arttı ve histopatolojik değişiklikler azaldı. VPA'nın neden olduğu pankreas hasarı, TQ'nun antioksidatif ve antiapoptotik etkileri nedeniyle hafifletildi. Sonuç: TQ, VPA'nın neden olduğu pankreas hasarının şiddetini azaltmada faydalı olabilir.

🔖

Cite This Article

AZİRAK, S., BİLGİÇ, S., KORKMAZ, D. T., SEVİMLİ, M., ÖZER, M. K. (2022). Effect of thymoquinone on ameliorating valproic acid-induced damage in pancreatic tissue of rats. Cukurova Medical Journal, Cilt: 47 - Sayı: 1, 350–359. https://ajindex.com/articles/399243

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Kumar R, Vidaurre J, Gedela S. Valproic acid-induced coagulopathy. Ped Neurol. 2019;98:25-30
  2. Zhu MM, Li HL, Shi LH, Chen XP, Luo J, Zhang ZL. The pharmacogenomics of valproic acid. J Hum Genet. 2017;62:1009-14
  3. Gerstner T, Bell N, König S. Oral valproic acid for epilepsy--long-term experience in therapy and side effects. Expert Opin Pharmacother. 2008;9:285-92
  4. Hamed SA. The effect of antiepileptic drugs on the kidney function and structure. Expert Rev Clin Pharmacol. 2017;10:993-1006
  5. Mai A, Massa S, Rotili D, Cerbara I, Valente S, Pezzi R et al. Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Med Res Rev. 2005;25:261-309
  6. Bahl S, Seto E. Regulation of histone deacetylase activities and functions by phosphorylation and its physiological relevance. Cell Moll Life Sci. 2021;78:427-45
  7. Sixto-López Y, Bello M, Correa-Basurto J. Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach. J Comput Aided Mol Des. 2020;34:857-78
  8. Miller KM, Tjeertes JV, Coates J, Legube G, Polo SE, Britton S et al. Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat Struct Mol Biol. 2010;17:1144-51
  9. Dovey OM, Foster CT, Conte N, Edwards SA, Edwards JM, Singh R, et al. Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice. Blood. 2013;121:1335-44
  10. Yang WB, Hsu CC, Hsu TI, Liou JP, Chang KY, Chen PY et al. Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma. Neuro-Oncol. 2020;22:1439- 51
  11. Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol. 2014;6:a018713
  12. Mazzoccoli G, Longhitano C, Vinciguerra M. Cardiohepatic metabolic derangements and valproic acid. Curr Clin Pharmacol. 2014;9:165-70
  13. Cornago M, Garcia-Alberich C, Blasco-Angulo N, Vall-Llaura N, Nager M, Herreros J et al. Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe. Cell Death Dis. 2014;5:e1435
  14. Lorberbaum DS, Docherty FM, Sussel L. Animal models of pancreas development, developmental disorders, and disease. Adv Exp Med Biol. 2020;1236:65-85
  15. Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015;386:85-96
  16. Wang GJ, Gao CF, Wei D, Wang C, Ding SQ. Acute pancreatitis: etiology and common pathogenesis. Wor